We are live on ! Find out more
O

OppenheimerFunds Portfolio holdings

AUM $80.4B
1-Year Est. Return 15.1%
This Fund
S&P 500
This Quarter Est. Return
+3.15%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
AUM
$79B
AUM Growth
-$678M
Cap. Flow
-$1.58B
Cap. Flow %
-2%
Top 10 Hldgs %
14.47%
Holding
1,865
New
144
Increased
1,078
Reduced
521
Closed
81

Top Sells

Rank Stock Value
1
LVS icon
Las Vegas Sands
LVS
+$462M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$398M
3
PYPL icon
PayPal
PYPL
+$265M
4
EA icon
Electronic Arts
EA
+$232M
5
GLW icon
Corning
GLW
+$208M

Sector Composition

Rank Sector Weight
1 Energy 16.61%
2 Financials 14.24%
3 Consumer Discretionary 11.15%
4 Healthcare 10.73%
5 Technology 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRAY
1551
DELISTED
Cray, Inc.
CRAY
$340K ﹤0.01%
16,449
+2,661
+19% +$54.8K
CBR
1552
DELISTED
CIBER Inc.
CBR
$340K ﹤0.01%
538,020
+280,585
+109% +$242K
GNTX icon
1553
Gentex
GNTX
$4.88B
$339K ﹤0.01%
17,202
+2,571
+18% +$46.8K
BELFB
1554
Bel Fuse Inc Class B
BELFB
$3.88B
$337K ﹤0.01%
10,920
-277
-2% -$7.71K
TGNA
1555
DELISTED
TEGNA Inc
TGNA
$337K ﹤0.01%
24,581
+2,948
+14% +$40.1K
HRB icon
1556
H&R Block
HRB
$5.18B
$336K ﹤0.01%
14,635
+957
+7% +$21.9K
RDS.B
1557
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$336K ﹤0.01%
5,800
-398
-6% -$21.8K
EBS icon
1558
Emergent Biosolutions
EBS
$375M
$335K ﹤0.01%
10,207
+923
+10% +$27.7K
BCPC
1559
Balchem Corp
BCPC
$5.23B
$334K ﹤0.01%
3,980
+112
+3% +$8.84K
MNST icon
1560
Monster Beverage
MNST
$91.4B
$332K ﹤0.01%
14,958
-972,390
-98% -$22.3M
UTHR icon
1561
United Therapeutics
UTHR
$26.3B
$331K ﹤0.01%
2,308
+322
+16% +$41.1K
NTRI
1562
DELISTED
NutriSystem, Inc.
NTRI
$331K ﹤0.01%
9,552
+1,002
+12% +$33.9K
AMRI
1563
DELISTED
Albany Molecular Research Inc
AMRI
$330K ﹤0.01%
17,574
+3,398
+24% +$57.8K
CRL icon
1564
Charles River Laboratories
CRL
$10.9B
$329K ﹤0.01%
4,319
-532,540
-99% -$40.4M
TBHC
1565
DELISTED
The Brand House Collective
TBHC
$329K ﹤0.01%
21,234
-1,600
-7% -$22.4K
TER icon
1566
Teradyne
TER
$54.8B
$329K ﹤0.01%
12,972
+1,047
+9% +$24.8K
CRVL icon
1567
CorVel
CRVL
$3.05B
$327K ﹤0.01%
26,811
+8,025
+43% +$91.8K
HF
1568
DELISTED
HFF Inc.
HF
$327K ﹤0.01%
10,798
+1,912
+22% +$54.5K
EVHC
1569
DELISTED
Envision Healthcare Holdings Inc
EVHC
$325K ﹤0.01%
+5,139
New +$336K
ACAT
1570
DELISTED
Arctic Cat Inc
ACAT
$325K ﹤0.01%
21,638
+1,605
+8% +$24.7K
INN
1571
Summit Hotel Properties
INN
$761M
$323K ﹤0.01%
20,164
+3,350
+20% +$47K
DO
1572
DELISTED
Diamond Offshore Drilling
DO
$323K ﹤0.01%
18,239
+7,494
+70% +$132K
HELE icon
1573
Helen of Troy
HELE
$663M
$322K ﹤0.01%
3,814
+1,058
+38% +$88.5K
MCHB
1574
Mechanics Bancorp
MCHB
$3.47B
$321K ﹤0.01%
+10,159
New +$291K
MSTR icon
1575
Strategy Inc
MSTR
$33.5B
$318K ﹤0.01%
16,120
+1,280
+9% +$24.2K

Similar funds

OppenheimerFunds's Q4 2016 Portfolio in Review

As of Q4 2016, OppenheimerFunds held 1,865 positions worth $79B, down 0.85% from $79.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

OppenheimerFunds's Q4 2016 filing shows 144 new, 1,078 increased, 521 reduced and 81 closed positions. Its largest new stake was Extra Space Storage: 1,003,416 shares worth $77.5M. The largest sale was Las Vegas Sands, an estimated $462M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Discretionary.

  • OppenheimerFunds's largest Q4 2016 buy was Extra Space Storage: 1,003,416 shares worth $77.5M.
  • OppenheimerFunds added most to Alphabet (Google) Class C in Q4 2016, an estimated $276M increase.
  • OppenheimerFunds's biggest Q4 2016 reduction was Las Vegas Sands, cutting an estimated $462M.
  • OppenheimerFunds fully exited Paycom in Q4 2016, selling an estimated $43.8M.
  • OppenheimerFunds's ten largest holdings make up 14% of its $79B portfolio in Q4 2016.
  • OppenheimerFunds opened 144 new positions and closed 81 in Q4 2016.
  • OppenheimerFunds's portfolio value fell 0.85% quarter-over-quarter to $79B.

Based on OppenheimerFunds's 13F filing for Q4 2016, filed 14 Feb 2017.